Marketing-authorisation holder · Cyprus
Medochemie Limited
292 medicines in 5 countries, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Cyprus
292 medicines in 5 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 292
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Aktiprol 200 mg tabletetableta | Amisulpride | Croatia | Marketed | 2020 |
| Aktiprol 400 mg tabletetableta | Amisulpride | Croatia | Authorised | 2020 |
| Aktiprol 50 mg tabletetableta | Amisulpride | Croatia | Not marketed | 2020 |
| ALFAGEM 1 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION1,165 g · Polvo para solución inyectable y para perfusión | Ceftazidime | Spain | Marketed | 2025 |
| ALFAGEM 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG2,330 g · Polvo para solución inyectable y para perfusión | Ceftazidime | Spain | Marketed | 2025 |
| Altecim 1 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Ceftazidime | Netherlands | Authorised | 2024 |
| Altecim 1 g prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Ceftazidime | Croatia | Not marketed | 2025 |
| Altecim 2 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie | Ceftazidime | Netherlands | Authorised | 2024 |
| Amirandes 2,32% gelGel | Diclofenac | Netherlands | Authorised | 2025 |
| APEL 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG600 mg · Comprimido recubierto con película | Linezolid | Spain | Marketed | 2020 |
| APREDONAV 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5.39 mg · Comprimido recubierto con película | Ivabradine | Spain | Marketed | 2019 |
| APREDONAV 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG8.085 mg · Comprimido recubierto con película | Ivabradine | Spain | Marketed | 2019 |
| Archifar 1000 mg prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Meropenem | Croatia | Marketed | 2020 |
| Archifar 500 mg prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Meropenem | Croatia | Marketed | 2020 |
| Areston 12,5 mg filmomhulde tablettenFilmomhulde tablet | Diclofenac | Netherlands | Authorised | 2017 |
| Aspendos 100 mg, tablettenTablet | Modafinil | Netherlands | Authorised | 2011 |
| Axetine 1500 mg prašak za otopinu za injekciju/infuzijuprašak za otopinu za injekciju/infuziju | Cefuroxime | Croatia | Marketed | 2015 |
| Axetine 750 mg prašak za otopinu za injekciju/infuzijuprašak za otopinu za injekciju/infuziju | Cefuroxime | Croatia | Marketed | 2015 |
| Azalonum 20 mg/40 mg tabletetableta | Cinnarizine, Dimenhydrinate | Croatia | Marketed | 2023 |
| Brotmin 1000 mg filmom obložene tablete*Filmom obložena tableta | Metformin | Croatia | Not marketed | 2022 |
| Brotmin 500 mg filmom obložene tablete*Filmom obložena tableta | Metformin | Croatia | Not marketed | 2022 |
| Brotmin 850 mg filmom obložene tablete*Filmom obložena tableta | Metformin | Croatia | Not marketed | 2022 |
| Bysimin 20 mg/ml otopina za injekcijuotopina za injekciju | Butylscopolamine | Croatia | Marketed | 2022 |
| Converide 150mg/12,5mg, filmomhulde tablettenFilmomhulde tablet | Hydrochlorothiazide, Irbesartan | Netherlands | Authorised | 2014 |
| Converide 300mg/12,5mg, filmomhulde tablettenFilmomhulde tablet | Hydrochlorothiazide, Irbesartan | Netherlands | Authorised | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Romania | 90 | 0 | 90 | CompaniesAll medicines |
| Croatia | 74 | 74 | 0 | CompaniesAll medicines |
| Spain | 58 | 52 | 6 | CompaniesAll medicines |
| Netherlands | 48 | 48 | 0 | CompaniesAll medicines |
| Saudi Arabia | 22 | 22 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.